Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Phibro Animal Health (PAHC) Cost of Revenue (2016 - 2025)

Historic Cost of Revenue for Phibro Animal Health (PAHC) over the last 14 years, with Q4 2025 value amounting to $241.3 million.

  • Phibro Animal Health's Cost of Revenue rose 1632.81% to $241.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $997.3 million, marking a year-over-year increase of 3227.52%. This contributed to the annual value of $896.3 million for FY2025, which is 2720.54% up from last year.
  • Phibro Animal Health's Cost of Revenue amounted to $241.3 million in Q4 2025, which was up 1632.81% from $244.1 million recorded in Q3 2025.
  • Phibro Animal Health's 5-year Cost of Revenue high stood at $268.7 million for Q2 2025, and its period low was $142.6 million during Q1 2021.
  • In the last 5 years, Phibro Animal Health's Cost of Revenue had a median value of $174.1 million in 2022 and averaged $185.8 million.
  • Per our database at Business Quant, Phibro Animal Health's Cost of Revenue fell by 15.38% in 2023 and then skyrocketed by 4444.5% in 2025.
  • Phibro Animal Health's Cost of Revenue (Quarter) stood at $162.0 million in 2021, then grew by 3.22% to $167.3 million in 2022, then rose by 2.43% to $171.3 million in 2023, then increased by 21.05% to $207.4 million in 2024, then rose by 16.33% to $241.3 million in 2025.
  • Its Cost of Revenue stands at $241.3 million for Q4 2025, versus $244.1 million for Q3 2025 and $268.7 million for Q2 2025.